Melanoma: where are we now? We interviewed on this topic Caroline Robert, Head of Dermatology Unit of the Gustave Roussy Cancer Campus Grand Paris, met at ESMO 2019 in Barcelona. She told us about the most recent data from the trials CheckMate067, IMMUNED and ABC on the combination nivolumab+ipilimumab and – in general – the new perspectives in melanoma treatment.
Andare in bici, per un oncologo come me, è una metafora della bellezza e delle difficoltà del nostro lavoro.
